Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

Obesity as a Disease: The Obesity Society 2018 Position Statement

(2018) Ania M. Jastreboff et al.   Obesity

Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs

(2016) KJ Lin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline

(2015) Caroline M. Apovian et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of attrition in a multidisciplinary adult weight management clinic

(2014) Richdeep Gill et al.   CANADIAN JOURNAL OF SURGERY

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study

(2014) Guangwei Li et al.   Lancet Diabetes & Endocrinology

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

(2013) J van Can et al.   INTERNATIONAL JOURNAL OF OBESITY

Adherence and Success in Long-Term Weight Loss Diets: The Dietary Intervention Randomized Controlled Trial (DIRECT)

(2013) Ilana Greenberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials

(2013) L. M. Warkentin et al.   Obesity Reviews

American Association of Clinical Endocrinologists' Position Statement on Obesity and Obesity Medicine

(2012) Jeffrey Mechanick et al.   Endocrine Practice

Impact of obesity, overweight and underweight on life expectancy and lifetime medical expenditures: the Ohsaki Cohort Study

(2012) Masato Nagai et al.   BMJ Open

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

(2011) R. R. Wing et al.   DIABETES CARE

Liraglutide: the therapeutic promise from animal models

(2010) L. B. Knudsen   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

(2009) Prospective Studies Collaboration   LANCET

Global burden of obesity in 2005 and projections to 2030

(2008) T Kelly et al.   INTERNATIONAL JOURNAL OF OBESITY